ePrints

Immunotherapy for intracranial metastatic melanoma

Lookup NU author(s): Andrew Bryant

Downloads

Full text for this publication is not currently held within this repository. Alternative links are provided below where available.

Abstract

Copyright © 2021 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.Objectives: This is a protocol for a Cochrane Review (intervention). The objectives are as follows:. To critically appraise the safety data of immunotherapy by identifying rates of toxicities focusing on neurologic adverse events. To compare the survival outcomes of immunotherapy including progression free survival, overall survival, and clinical response rate. To appraise evidence-based treatments for intracranial metastatic melanoma.

Publication metadata

Author(s): Tang HKC, Peters C, Rao A, Patel P, Bryant A

Publication type: Article

Publication status: Published

Journal: Cochrane Database of Systematic Reviews

Year: 2021

Volume: 2021

Issue: 4

Online publication date: 19/04/2021

Acceptance date: 02/04/2018

ISSN (electronic): 1469-493X

Publisher: John Wiley and Sons Ltd

URL: https://doi.org/10.1002/14651858.CD014588

DOI: 10.1002/14651858.CD014588

Altmetrics

Share